ENTITY
Sanofi Eyes COPD Treatment as Major Growth Driver for Dupixent, Says CEO
Sanofi, Dupixent, COPD, growth pillar, immunology, CEO, treatment, expansion, clinical trials, asthma, atopic dermatitis.
Novo Nordisk Faces Scrutiny Over High Prices of Ozempic and Wegovy
Novo Nordisk, Ozempic, Wegovy, drug prices, Senator Bernie Sanders, diabetes, obesity
UCB’s Strategic Shift: Bristol Myers ADC Partner’s CEO Takes the Helm
UCB, management changes, CEO, Bristol Myers, ADC partner, strategic shift, pharmaceutical industry.
Gilead’s Strategic Focus: CymaBay Liver Drug, Trodelvy Data, and Long-Acting PrEP in 2023
Gilead, CymaBay, liver drug, Trodelvy, readouts, long-acting PrEP, 2023, strategic focus.
BMS Realigns Workforce Post-Mergers and Acquisitions: A Strategic Move Affecting 2,200 Employees
BMS, layoffs, mergers and acquisitions, workforce realignment, strategic move, 2, 200 employees
GSK Files Lawsuit Against Pfizer and BioNTech for Alleged COVID-19 Vaccine Patent Violation
GSK, Pfizer, BioNTech, COVID-19, patent infringement, vaccine, lawsuit, intellectual property
Endo’s Par Pharmaceutical Recalls Blood Pressure Medication Due to Potential Contamination
Endo, Par Pharmaceutical, recall, blood pressure medication, contamination, quinapril HCl/ hydrochlorothiazide tablets, USP 20 mg/12.5 mg, lot number 0KG190092, expiration date 03/2022
Walgreens Expands into Specialty Pharmacy and Therapy Services
Walgreens, specialty pharmacy, drug services, therapy services, healthcare, expansion
Bristol Myers and Cellares Collaborate on Global CAR-T Manufacturing Deal
Bristol Myers, Cellares, CAR-T, biopharma, manufacturing partners, diversification, global deal
Lilly Acquires Injectable Medicines Production Facility from Nexus Pharma
Lilly, Nexus Pharma, injectable medicines, facility acquisition, pharmaceutical manufacturing, strategic expansion, production capacity.